ArticleFrontiers in bioengineering and biotechnology2023

Reduction-responsive supramolecular hybridized paclitaxel nanoparticles for tumor treatment.

Yuhan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.